BACKGROUND: Prenatal supplements are often recommended to pregnant women to help meet their nutrient needs. Many products are available, making it difficult to choose a suitable supplement because little is known about their labeling and contents to evaluate their appropriateness. OBJECTIVE: To determine differences between prescription and nonprescription prenatal supplements available in the United States regarding declared nutrient and nonnutrient ingredients and the presence of dosing and safety-related information. DESIGN: Using two publicly available databases with information about prenatal supplement products, information from prescription and nonprescription product labels were extracted and evaluated. For the 82 prescription and 132 nonprescription products, declared label amounts of seven vitamins and minerals, docosahexaenoic acid (DHA), the presence of other nonnutrient components, and the presence of key safety and informational elements as identified in two Department of Health and Human Services Office of Inspector General (OIG)'s 2003 reports were compiled and compared. RESULTS: Compared with nonprescription products, prescription products contained significantly fewer vitamins (9±0.2 vs 11±0.3; P≤0.05) and minerals (4±0.1 vs 8±0.3; P≤0.05). Declared amounts of folic acid were higher in prescription products, whereas vitamin A, vitamin D, iodine, and calcium were higher in the nonprescription products. Amounts of iron, zinc, and DHA were similar. Virtually all products contained levels of one or more nutrients that exceeded the Recommended Dietary Allowances for pregnant and/or lactating women. Product type also influenced ingredients added. Fewer prescription products contained botanical ingredients (6% prescription vs 33% nonprescription) and probiotics (2% prescription vs 8% nonprescription). Only prescription products contained the stool softener docusate sodium. CONCLUSIONS: Our analysis of prenatal supplements indicates that prescription and nonprescription supplements differ in terms of declared composition and nutrient strength, but have labels that are similarly sparse regarding aspects of use such as dosing information.
BACKGROUND: Prenatal supplements are often recommended to pregnant women to help meet their nutrient needs. Many products are available, making it difficult to choose a suitable supplement because little is known about their labeling and contents to evaluate their appropriateness. OBJECTIVE: To determine differences between prescription and nonprescription prenatal supplements available in the United States regarding declared nutrient and nonnutrient ingredients and the presence of dosing and safety-related information. DESIGN: Using two publicly available databases with information about prenatal supplement products, information from prescription and nonprescription product labels were extracted and evaluated. For the 82 prescription and 132 nonprescription products, declared label amounts of seven vitamins and minerals, docosahexaenoic acid (DHA), the presence of other nonnutrient components, and the presence of key safety and informational elements as identified in two Department of Health and Human Services Office of Inspector General (OIG)'s 2003 reports were compiled and compared. RESULTS: Compared with nonprescription products, prescription products contained significantly fewer vitamins (9±0.2 vs 11±0.3; P≤0.05) and minerals (4±0.1 vs 8±0.3; P≤0.05). Declared amounts of folic acid were higher in prescription products, whereas vitamin A, vitamin D, iodine, and calcium were higher in the nonprescription products. Amounts of iron, zinc, and DHA were similar. Virtually all products contained levels of one or more nutrients that exceeded the Recommended Dietary Allowances for pregnant and/or lactating women. Product type also influenced ingredients added. Fewer prescription products contained botanical ingredients (6% prescription vs 33% nonprescription) and probiotics (2% prescription vs 8% nonprescription). Only prescription products contained the stool softener docusate sodium. CONCLUSIONS: Our analysis of prenatal supplements indicates that prescription and nonprescription supplements differ in terms of declared composition and nutrient strength, but have labels that are similarly sparse regarding aspects of use such as dosing information.
Authors: Johanna T Dwyer; Joanne Holden; Karen Andrews; Janet Roseland; Cuiwei Zhao; Amy Schweitzer; Charles R Perry; James Harnly; Wayne R Wolf; Mary Frances Picciano; Kenneth D Fisher; Leila G Saldanha; Elizabeth A Yetley; Joseph M Betz; Paul M Coates; John A Milner; Jackie Whitted; Vicki Burt; Kathy Radimer; Jaime Wilger; Katherine E Sharpless; Constance J Hardy Journal: Anal Bioanal Chem Date: 2007-07-20 Impact factor: 4.142
Authors: Karen W Andrews; Janet M Roseland; Pavel A Gusev; Joel Palachuvattil; Phuong T Dang; Sushma Savarala; Fei Han; Pamela R Pehrsson; Larry W Douglass; Johanna T Dwyer; Joseph M Betz; Leila G Saldanha; Regan L Bailey Journal: Am J Clin Nutr Date: 2016-12-14 Impact factor: 7.045
Authors: Delan Devakumar; Caroline H D Fall; Harshpal Singh Sachdev; Barrie M Margetts; Clive Osmond; Jonathan C K Wells; Anthony Costello; David Osrin Journal: BMC Med Date: 2016-06-16 Impact factor: 8.775
Authors: Carin Andrén Aronsson; Kendra Vehik; Jimin Yang; Ulla Uusitalo; Kristen Hay; Gesa Joslowski; Anne Riikonen; Lori Ballard; Suvi M Virtanen; Jill M Norris Journal: Public Health Nutr Date: 2013-03-04 Impact factor: 4.539
Authors: Leila G Saldanha; Johanna T Dwyer; Richard A Bailen; Karen W Andrews; Joseph W Betz; Hua F Chang; Rebecca B Costello; Abby G Ershow; Jeanne Goshorn; Constance J Hardy; Paul M Coates Journal: J Nutr Date: 2018-08-01 Impact factor: 4.798
Authors: Johanna T Dwyer; Richard A Bailen; Leila G Saldanha; Jaime J Gahche; Rebecca B Costello; Joseph M Betz; Cindy D Davis; Regan L Bailey; Nancy Potischman; Abby G Ershow; Barbara C Sorkin; Adam J Kuszak; Luisa Rios-Avila; Florence Chang; Jeanne Goshorn; Karen W Andrews; Pamela R Pehrsson; Pavel A Gusev; James M Harnly; Constance J Hardy; Nancy J Emenaker; Kirsten A Herrick Journal: J Nutr Date: 2018-08-03 Impact factor: 4.798
Authors: Julie M Petersen; Mahsa M Yazdy; Kelly D Getz; Marlene T Anderka; Martha M Werler Journal: Am J Clin Nutr Date: 2021-06-01 Impact factor: 7.045
Authors: Julie M Petersen; Samantha E Parker; Corey M Benedum; Allen A Mitchell; Sarah C Tinker; Martha M Werler Journal: Birth Defects Res Date: 2019-08-21 Impact factor: 2.661
Authors: Katharine K Brieger; Kelly M Bakulski; Celeste L Pearce; Ana Baylin; John F Dou; Jason I Feinberg; Lisa A Croen; Irva Hertz-Picciotto; Craig J Newschaffer; M Daniele Fallin; Rebecca J Schmidt Journal: J Autism Dev Disord Date: 2021-06-10